Skip to main content

Year: 2025

NANO Nuclear Energy Closes $400 Million Oversubscribed Private Placement of Common Stock with Preeminent Institutional Investors

NANO Nuclear Energy Inc.NANO Nuclear Energy Closes $400 Million Oversubscribed Private Placement of Common Stock with Preeminent Institutional InvestorsFinancing provides NANO Nuclear with financial flexibility and multiple years of operating runway in the race to develop the first advanced micro nuclear reactor in the U.S.Financing raised at highest valuation to date; cash position is now approximately $600 million New York, NY, Oct. 10, 2025 (GLOBE NEWSWIRE) — NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company, today announced the closing of its previously announced private placement of common stock for gross Primary participation in the private placement included an initial investment from preeminent asset managers alongside several new...

Continue reading

AB Science today reports its revenues for the first half of 2025 and provides an update on its activities

        PRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2025 AND KEY EVENTS DURING THE PERIODFinancial and corporate situationOperating deficit reduced by 24% compared to the first half of 2024, amounting to €2.7 million as of June 30, 2025 Capital increase through private placements for a total amount of €6.3 millionClinical developmentMasitinib platform:Authorization from several European countries for the confirmatory Phase 3 study with masitinib in amyotrophic lateral sclerosis FDA and EMA authorization for the Phase 3 confirmatory study with masitinib in metastatic hormone-resistant prostate cancer New data demonstrating the efficacy of masitinib in Alzheimer’s disease U.S. patent granted covering masitinib until 2040 for the treatment of sickle cell diseaseMicrotubule platform:Regulatory...

Continue reading

Datavault AI Regains Compliance with Nasdaq Minimum Bid Price Requirement

BEAVERTON, Ore., Oct. 10, 2025 (GLOBE NEWSWIRE) — via IBN — Datavault AI Inc. (Nasdaq: DVLT), a leader in secure data tokenization and Web 3.0 innovations, today announced that it has received official notification from The Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) relating to the minimum bid price requirement for its common stock. According to Nasdaq’s notice, Datavault AI’s common stock maintained a closing bid price of at least $1.00 per share for ten consecutive trading days, from September 26, 2025 to October 9, 2025. As a result, Nasdaq has determined that Datavault AI has satisfactorily met the requirements to continue its listing on the Nasdaq Capital Market. No further actions are required by the Company in connection...

Continue reading

One and One Green Technologies. INC Announces Closing of Initial Public Offering

San Rafael, Bulacan, Philippines, Oct. 10, 2025 (GLOBE NEWSWIRE) — One and one Green Technologies. INC (the “Company”) (NASDAQ: YDDL), a waste materials and scrap metal recycling company in the Philippines, today announced the closing of its initial public offering (the “Offering”) of 2,000,000 class A ordinary shares, par value $0.0001 per share (“Class A Ordinary Shares”), at a public offering price of $5.00 per share to the public. The Company’s Class A Ordinary Shares began trading on the Nasdaq Capital Market on October 9, 2025, under the ticker symbol “YDDL.” The Company received aggregate gross proceeds of $10,000,000 from the offering, before deducting underwriting discounts and other offering expenses. In addition, the Company has granted a 30-day option to the underwriters to purchase up to 300,000 additional Class A...

Continue reading

KLÉPIERRE: INFORMATION REGARDING THE TOTAL VOTING RIGHTS AND SHARES OF KLÉPIERRE SA AS OF SEPTEMBER 30, 2025

REGULATED RELEASE INFORMATION REGARDING THE TOTAL VOTING RIGHTS AND SHARES OF KLÉPIERRE SA AS OF SEPTEMBER 30, 2025(1) Paris – October 10, 2025 NUMBER OF SHARES AS OF SEPTEMBER 30, 2025Date 09/30/2025Company name KlépierreTrading place Euronext Paris (Compartment A)Mnemonic LISymbols EPA:LI / LI:FP / LOIM.PAISIN FR0000121964Total number of shares 286,861,172Total number of voting rights  Number of theoretical voting rights(2) 286,861,172Number of exercisable voting rights(3)  286,310,633AGENDA  October 22, 2025February 19, 2026 Trading update for the first nine months of 2025 (after market closing)2025 full-year earnings (after market closing)INVESTOR RELATIONS CONTACTS    Paul Logerot, Group Head of Investor Relations and Financial Communication +33 (0)7 50 66 05 63 — paul.logerot@klepierre.comHugo...

Continue reading

Societe Generale: shares and voting rights as of 30 September 2025

NUMBER OF SHARES COMPOSING CURRENT SHARE CAPITAL AND TOTAL NUMBER OF VOTING RIGHTS AS OF 30 SEPTEMBER 2025 Regulated Information Paris, 10 October 2025 Information about the total number of voting rights and shares pursuant to Article L.233-8 II of the French Commercial Code and Article 223-16 of the AMF General Regulations.Date Number of shares composing current share capital Total number ofvoting rights30 September 2025785,180,327  Gross: 871,965,338Press contacts: ean-Baptiste Froville_+33 1 58 98 68 00_ jean-baptiste.froville@socgen.comFanny Rouby_+33 1 57 29 11 12_ fanny.rouby@socgen.com Societe Generale Societe Generale is a top tier European Bank with around 119,000 employees serving more than 26 million clients in 62 countries across the world. We have been supporting the development of our economies for 160 years,...

Continue reading

Webcast – Invitation to Investor Presentation

Ensurge Micropower ASA (OSE: ENSU)  Shauna McIntyre (CEO) will host a webcast at 10:00 CET Tuesday 14 October 2025.   The webcast can be accessed through the following link:  https://teams.microsoft.com/l/meetup-join/19%3ameeting_YjYwYzIzMzYtNzRkZS00NzNlLWEzNGItNDFjZmI5M2QzZjBm%40thread.v2/0?context=%7b%22Tid%22%3a%22d02701f9-3b23-4b3f-8fce-29ed54632bf8%22%2c%22Oid%22%3a%2249eee719-db83-4ef4-aca0-334090732543%22%7d For more information, please contact: Lars Eikeland, CFO E- mail: lars.eikeland@ensurge.com Ståle Bjørnstad (IR)E-mail: stale.bjornstad@ensurge.com

Continue reading

American Oncology Network Presents 15 Research Abstracts at ASCO Quality 2025

FORT MYERS, Fla., Oct. 10, 2025 (GLOBE NEWSWIRE) — American Oncology Network (AON), one of the fastest-growing community oncology networks in the nation, announced today that 15 research abstracts by AON physicians and leaders have been accepted for presentation at the American Society of Clinical Oncology (ASCO) Quality Care Symposium 2025. The event, themed Driving Solutions, Implementing Change, takes place Oct. 10-11 in Chicago. AON leaders will present on a variety of topics including the Inflation Reduction Act’s influence on Enhancing Oncology Model (EOM) Part D expenditures and total cost of care (Abstract #2) and Inflation’s Toll on Oncology Physician Reimbursement (Abstract #21).A full list of AON physician and leader abstracts at the ASCO Quality Care Symposium include:Navigating New Norms: The Inflation Reduction...

Continue reading

Northland Power Announces Its Third Quarter 2025 Financial Results Release Date and Provides Investor Call and Webcast Details

TORONTO, Oct. 10, 2025 (GLOBE NEWSWIRE) — Northland Power Inc. (“Northland”) (TSX: NPI) announces it will release its 2025 third quarter operating and financial results after markets close on Wednesday, November 12, 2025. Northland’s management will hold an investor conference call and webcast at 10 a.m. Eastern Time (ET) on Thursday, November 13, 2025, followed by a question and answer period with analysts. Conference call details: Date: Thursday, November 13, 2025 Start Time: 10:00 a.m. ET Participants wishing to join the call and ask questions must register using the following URL below: https://register-conf.media-server.com/register/BI5f9ddfa224de42c59acee20c0b94c41a For all other attendees, the call will be broadcast live on the internet, in listen-only mode and can be accessed using the following link: Webcast URL:...

Continue reading

Shuttle Executes LOI with Molecule.ai

GAITHERSBURG, Md., Oct. 10, 2025 (GLOBE NEWSWIRE) — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company, today announced the execution of a non-binding letter of Intent with Molecule.ai. Molecule.ai, a pioneering artificial intelligence company founded by AI scientist and researcher Dr. ZT Zhang, PhD, today announced the execution of a letter of Intent to acquire Molecule.ai and its state-of-the-art platform designed to transform the way pharmaceutical and biotech companies discover and develop new therapeutics. By leveraging advanced machine learning models, including large language models (LLMs), Molecule.ai delivers industry-leading accuracy and efficiency in evaluating novel molecules. The platform enables researchers...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.